GlassScriptPhysician profile
Jeffrey G Deloach
NPI 1295849966
$494.06
in general payments reported to CMS, 2019-2025
14 companies · $19.96 in 2025
The $19.96 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $31.85 · 2021: $15.67 · 2023: $15.94 · 2024: $65.08 · 2025: $19.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $159.03 | 2019-2023 | Proclaim |
| Orthofix Medical, INC. | $64.42 | 2019-2024 | Physio-Stim |
| Bioventus LLC | $64.42 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $30.87 | 2019 | |
| Orthogenrx INC. | $25.67 | 2019 | |
| Amgen INC. | $24.76 | 2019 | |
| Kerecis Limited | $22.68 | 2019 | |
| Pacira Therapeutics, INC. | $18.24 | 2020 | |
| Ferring Pharmaceuticals INC. | $16.30 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.70 | 2019 | |
| Acell, INC. | $14.55 | 2019 | |
| Endo Pharmaceuticals INC. | $13.61 | 2020 | |
| Depuy Synthes Sales INC. | $12.71 | 2019 | |
| Radius Health, INC. | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Deloach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.